204 related articles for article (PubMed ID: 8216208)
21. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type.
Ruppert C; Pucker C; Markart P; Schmidt R; Grimminger F; Seeger W; Stürzebecher J; Günther A
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):95-102. PubMed ID: 12495937
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.
Veldhuizen RA; McCaig LA; Akino T; Lewis JF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748
[TBL] [Abstract][Full Text] [Related]
24. SP-A, SP-B, and SP-C in surfactant subtypes around birth: reexamination of alveolar life cycle of surfactant.
Baritussio A; Alberti A; Quaglino D; Pettenazzo A; Dalzoppo D; Sartori L; Pasquali-Ronchetti I
Am J Physiol; 1994 Apr; 266(4 Pt 1):L436-47. PubMed ID: 8179020
[TBL] [Abstract][Full Text] [Related]
25. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
26. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation.
Veldhuizen RA; Lee J; Sandler D; Hull W; Whitsett JA; Lewis J; Possmayer F; Novick RJ
Am Rev Respir Dis; 1993 Jul; 148(1):208-15. PubMed ID: 8317801
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants.
Haddad IY; Ischiropoulos H; Holm BA; Beckman JS; Baker JR; Matalon S
Am J Physiol; 1993 Dec; 265(6 Pt 1):L555-64. PubMed ID: 8279572
[TBL] [Abstract][Full Text] [Related]
28. In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs.
Higuchi R; Lewis J; Ikegami M
Am Rev Respir Dis; 1992 Jun; 145(6):1416-20. PubMed ID: 1596011
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro.
Beatty AL; Malloy JL; Wright JR
Am J Respir Cell Mol Biol; 2005 Feb; 32(2):128-34. PubMed ID: 15528490
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight hydrophobic proteins from bovine pulmonary surfactant.
Mathialagan N; Possmayer F
Biochim Biophys Acta; 1990 Jul; 1045(2):121-7. PubMed ID: 2378907
[TBL] [Abstract][Full Text] [Related]
31. Identification of surfactant proteolipid SP-B in human surfactant and fetal lung.
Weaver TE; Sarin VK; Sawtell N; Hull WM; Whitsett JA
J Appl Physiol (1985); 1988 Aug; 65(2):982-7. PubMed ID: 2459102
[TBL] [Abstract][Full Text] [Related]
32. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
33. Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases.
Schochett P; Mora R; Mark L; Butler M; Ingenito EP
Exp Lung Res; 1999; 25(7):595-616. PubMed ID: 10598320
[TBL] [Abstract][Full Text] [Related]
34. Binding of calcium to SP-A, a surfactant-associated protein.
Haagsman HP; Sargeant T; Hauschka PV; Benson BJ; Hawgood S
Biochemistry; 1990 Sep; 29(38):8894-900. PubMed ID: 2271565
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary surfactant activity is impaired in lung transplant recipients.
Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
[TBL] [Abstract][Full Text] [Related]
36. Protein-lipid interactions and enzyme requirements for light subtype generation on cycling reconstituted surfactant.
Dhand R; Sharma VK; Teng AL; Krishnasamy S; Gross NJ
Biochem Biophys Res Commun; 1998 Mar; 244(3):712-9. PubMed ID: 9535730
[TBL] [Abstract][Full Text] [Related]
37. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants.
Griese M; Wilnhammer C; Jansen S; Rinker C
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):237-44. PubMed ID: 10424996
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary surfactant metabolism in infants lacking surfactant protein B.
Beers MF; Hamvas A; Moxley MA; Gonzales LW; Guttentag SH; Solarin KO; Longmore WJ; Nogee LM; Ballard PL
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):380-91. PubMed ID: 10696076
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of immunohistochemical staining with pulmonary surfactant protein A among fractionated alveolar macrophages which involves metabolism of pulmonary surfactant.
Sakai K; Kohri T; Kawaguchi Y; Kweon MN; Kishino Y
Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):853-60. PubMed ID: 1477601
[TBL] [Abstract][Full Text] [Related]
40. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.
Atochina EN; Beers MF; Scanlon ST; Preston AM; Beck JM
Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L599-609. PubMed ID: 10710533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
